Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.

Uchino K, Obi S, Tateishi R, Sato S, Kanda M, Sato T, Arano T, Enooku K, Goto E, Masuzaki R, Nakagawa H, Asaoka Y, Kondo Y, Yamashiki N, Goto T, Shiina S, Omata M, Yoshida H, Koike K
J Gastroenterol. 2012 47 (10): 1152-9

PMID: 22438097 · DOI:10.1007/s00535-012-0574-3

MeSH Terms (23)

Adult Aged Aged, 80 and over Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Antiviral Agents Carcinoma, Hepatocellular Cohort Studies Female Fluorouracil Humans Infusions, Intravenous Injections, Subcutaneous Interferon-alpha Japan Liver Neoplasms Male Middle Aged Polyethylene Glycols Recombinant Proteins Retrospective Studies Survival Rate Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: